0001140361-17-010118.txt : 20170301 0001140361-17-010118.hdr.sgml : 20170301 20170301205730 ACCESSION NUMBER: 0001140361-17-010118 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170223 FILED AS OF DATE: 20170301 DATE AS OF CHANGE: 20170301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIGEN CORP CENTRAL INDEX KEY: 0000730272 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 042729386 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7814499560 MAIL ADDRESS: STREET 1: 41 SEYON STREET STREET 2: BUILDING 1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02453 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Snodgres Jon CENTRAL INDEX KEY: 0001613498 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14656 FILM NUMBER: 17656704 MAIL ADDRESS: STREET 1: REPLIGEN CORPORATION, 41 SEYON STREET STREET 2: BUILDING #1, SUITE 100 CITY: WALTHAM STATE: MA ZIP: 02435 4 1 doc1.xml FORM 4 X0306 4 2017-02-23 0 0000730272 REPLIGEN CORP RGEN 0001613498 Snodgres Jon C/O REPLIGEN CORPORATION 41 SEYON ST, BLDG 1, STE 100 WALTHAM MA 02453 0 1 0 0 Chief Financial Officer Common Stock 2017-02-23 4 A 0 9875 0 A 27328 D Common Stock 2017-03-01 4 F 0 1630 32.0693 D 25698 D Stock Option (Right to Buy) 32.32 2017-02-23 4 A 0 19750 0.00 A 2027-02-23 Common Stock 19750 19750 D Mr. Snodgres was awarded 9,875 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Payment of tax liability made via forfeiture of 1,630 shares of Common Stock valued at a weighted average price of $32.0693 per share on March 1, 2017. The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. /s/ Jeffrey P. Leduc (Attorney in Fact) 2017-03-01